56077-47-5

Basic information

• Product Name: Acetic acid, (4-mercapto-2-methylphenoxy)-, methyl ester
• CAS NO: 56077-47-5
• Molecular Formula: C10H12O3S
• Molecular Weight: 212.269
• Mol File: 56077-47-5.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Acetic acid, (4-mercapto-2-methylphenoxy)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Acetic acid, (4-mercapto-2-methylphenoxy)-, methyl ester(56077-47-5)
• EPA Substance Registry System: Acetic acid, (4-mercapto-2-methylphenoxy)-, methyl ester(56077-47-5)

Safety Data

• Hazardous Substances Data: 56077-47-5(Hazardous Substances Data)

Upstream product

• 583883-85-6 (4-dimethylcarbamoylsulfanyl-2-methyl-phenoxy)-acetic acid methyl ester 
• 56077-64-6 (2-Methyl-4-thiocyanato-phenoxy)-acetic acid methyl ester 
• 2989-17-5 methyl 2-methylphenoxy acetate 
• 95-48-7 ortho-cresol 
• 876-02-8 4-hydroxy-3-methylphenyl methyl ketone 
• 317319-10-1 methyl (4-hydroxy-2-methylphenoxy)acetate 
• 91427-62-2 (4-chlorosulfonyl-2-methyl-phenoxy)-acetic acid ethyl ester 
• 93917-68-1 ethyl (2-methylphenoxy)acetate 
• 67-56-1 methanol 
• 583883-84-5 (4-dimethylthiocarbamoyloxy-2-methyl-phenoxy)-acetic acid methyl ester 
• 317319-09-8 (4-acetoxy-2-methylphenoxy)acetic acid methyl ester 
• 166953-80-6 (4-acetyl-2-methylphenoxy)acetic acid methyl ester 

Downstream Products

• 873066-40-1 {4-[4-furan-2-yl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-2-methyl-phenoxy}-acetic acid methyl ester 
• 873066-41-2 {2-methyl-4-[4-phenyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-phenoxy}-acetic acid methyl ester 
• 919285-71-5 {4-[3-(2,6-dichloro-phenyl)-isoxazol-5-ylmethylsulfanyl]-2-methyl-phenoxy}-acetic acid methyl ester 
• 613239-70-6 {2-Methyl-4-[4-(4-trifluoromethyl-benzyloxy)-benzylsulfanyl]-phenoxy}-acetic Acid Methyl Ester 
• 613239-53-5 [4-(Biphenyl-4-ylmethylsulfanyl)-2-methyl-phenoxy]-acetic Acid Methyl Ester 
• 613239-66-0 [4-(4-benzyloxy-benzylsulfanyl)-2-methyl-phenoxy]-acetic acid mehyl ester 
• 918164-59-7 methyl (2-methyl-4-[4-methyl-5-(4-trifluoromethylphenyl)thien-2-ylmethylthio]phenoxy)acetate 
• 918164-60-0 methyl (2-methyl-4-[3-methyl-5-(4-trifluoromethylphenyl)thien-2-ylmethylthio]phenoxy)acetate 
• 719293-47-7 [4-(3-{4'-[3-(4-methoxycarbonylmethoxy-3-methyl-phenylsulfanyl)-propyl]-2,2'-bis-trifluoromethyl-biphenyl-4-yl}-propylsulfanyl)-2-methyl-phenoxy]-acetic acid methyl ester 
• 613240-25-8 {2-Methyl-4-[3-(4-trifluoromethyl-phenyl)-isoxazol-5-ylmethylsulfanyl]-phenoxy}-acetic Acid Methyl Ester 
• 613240-05-4 [4-(4-Acetoxy-benzylsulfanyl)-2-methyl-phenoxy]-acetic Acid Methyl Ester 
• 613239-74-0 [4-(9H-fluoren-2-ylmethylsulfanyl)-2-methyl-phenoxy]-acetic acid methyl ester 

Relevant articles and documents

Base Catalysis Enables Access to α,α-Difluoroalkylthioethers

A nucleophilic addition reaction of aryl thiols to readily available β,β-difluorostyrenes provides α,α-difluoroalkylthioethers. The reaction proceeds through an unstable anionic intermediate, prone to eliminate fluoride and generate α-fluorovinylthioethers. However, the use of base catalysis overcomes the facile β-fluoride elimination, generating α,α-difluoroalkylthioethers in excellent yields and selectivities.

DICARBOXYLIC ACID DERIVATIVES AS PPAR-AGONISTS

A novel class of dicarboxylic acid derivatives, the use of these compounds as phar-maceutical compositions, pharmaceutical compositions comprising the compounds and meth-ods of treatment employing these compounds and compositions. The present compounds may be useful in the treatment and/or prevention of conditions mediated by Peroxisome Prolifera-tor-Activated Receptors (PPAR).

Compounds that modulate PPAR activity and methods of preparation

This invention relates to compounds that alter PPAR activity. The invention also relates to pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds or their salts, and methods of using them as therapeutic agents for treating or preventing dyslipidemia, hypercholesterolemia, obesity, hyperglycemia, atherosclerosis, hypertriglyceridemia and hyperinsulinemia in a mammal. The present invention also relates to methods for making the disclosed compounds.